Delivery Order SPE2DB24D9802-SPE2DB26FJKTP
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,496.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Beyfortus 50 mg/0.5 mL syringes. The delivery order, issued on October 20, 2025, with an ultimate completion date of October 21, 2025, operates under a firm fixed-price structure with no set-aside designation, allowing DMS Pharmaceutical Group to compete directly against all...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,834.34 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Beyfortus 100 mg/mL syringes. The award was issued on October 20, 2025, with an ultimate completion date of October 21, 2025, with no set-aside designation applied. DMS Pharmaceutical Group, registered in the System for Award Management since 2001, is serving...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $18,107.70 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, which runs through February 2, 2024, is for the supply of the pharmaceutical product BEYFORTUS 100 MG/ML SYRINGEML. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, holding a significant indefinite delivery contract (IDC) with the DLA under the...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $15,032.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract covers the procurement of BEYFORTUS 100 MG/ML SYRINGEML, with a completion date of September 30, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) under the SPE2DB program, valued at up to $499,999,999, which allows...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $9,053.85 order is for BEYFORTUS 100 MG/ML SYRINGEML and is part of a larger, single-award indefinite delivery contract valued up to $4,999,999 through 2025. The contract enables DLA to issue delivery orders for a broad range of pharmaceutical items to fulfill the recurring medical supply needs of military...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,978.75 contract is for the delivery of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML and has a completion date of July 9, 2024. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,546.76 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of SYFOVRE 15 mg/0.1 mL vials. The award, issued on October 16, 2025, with an ultimate completion date of November 6, 2025, utilizes firm fixed-price pricing and carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal...
- The Defense Logistics Agency awarded a delivery order valued at $16,332.86 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on September 24, 2025. The contract calls for delivery of Beyfortus 50 mg/0.5 ml syringes and is structured as a firm fixed-price delivery order with an ultimate completion date of September 25, 2025. Performance will occur in Conshohocken, Pennsylvania. This award was made without a set-aside designation, allowing DMS Pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,917.34 firm fixed-price delivery order is for BEYFORTUS 100 MG/ML SYRINGEML, a pharmaceutical product, under the DLA's Medical Supply Chain program. The contract does not have a set-aside designation. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,711.25 delivery order is for the supply of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, to support the medical needs of military healthcare facilities. The contract is a firm fixed-price delivery order and is not associated with a set-aside designation. DMS Pharmaceutical...
- SPE2DB24D9802Indefinite Delivery Contract
- SPE2DB24D9802-SPE2DB26FJKTPDelivery Order
The Defense Logistics Agency awarded a $3,559.66 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Beyfortus 50 mg/0.5 ml syringes. The delivery order, issued on October 20, 2025, with an ultimate completion date of October 21, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy established to support recurring pharmaceutical supply needs across Department of Defense healthcare facilities globally. DMS Pharmaceutical Group serves as a critical regional pharmaceutical supplier within the PPV-G GEN V framework, which authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for branded and generic prescription drugs, biologics, and medical consumables. The company's primary contract under this vehicle, designated SPE2DR, carries a $499,999,999.00 ceiling value and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. The current award represents one of numerous delivery orders the contractor has fulfilled for DLA's Medical Supply Chain division, reflecting its established performance in supplying specialized pharmaceutical products to support military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 10/20/25 |